Imaging the Effects of Methylphenidate on Brain Dopamine: New Model on Its Therapeutic Actions for Attention-Deficit/Hyperactivity Disorder

Biological Psychiatry - Tập 57 - Trang 1410-1415 - 2005
Nora D. Volkow1,2,3, Gene-Jack Wang3, Joanna S. Fowler4, Yu-Shin Ding4
1National Institute on Drug Abuse, Bethesda, Maryland
2National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland
3Medical Department, Brookhaven National Laboratory, Upton, New York
4Chemistry Department, Brookhaven National Laboratory, Upton, New York

Tài liệu tham khảo

Aman, 1998, A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder, Dev Psychol, 34, 956, 10.1037/0012-1649.34.5.956 Berridge, 1998, What is the role of dopamine in reward, Brain Res Brain Res Rev, 28, 309, 10.1016/S0165-0173(98)00019-8 Bush, 1999, Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop, Biol Psychiatry, 45, 1542, 10.1016/S0006-3223(99)00083-9 Cardinal, 2001, Impulsive choice induced in rats by lesions of the nucleus accumbens core, Science, 292, 2499, 10.1126/science.1060818 Castellanos, 1997, Toward a pathophysiology of attention-deficit/hyperactivity disorder, Clin Pediatr (Phila), 36, 381, 10.1177/000992289703600702 Castellanos, 1996, Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder, Neuropsychopharmacology, 14, 125, 10.1016/0893-133X(95)00077-Q Conners, 1966, The effect of dexedrine on rapid discrimination and motor control of hyperkinetic children under mild stress, J Nerv Ment Dis, 142, 429, 10.1097/00005053-196605000-00005 Cook, 1995, Association of attention-deficit disorder and the dopamine transporter gene, Am J Hum Genet, 56, 993 Ding, 1997, Chiral drugs, Psychopharmacology (Berl), 131, 71, 10.1007/s002130050267 Dinn, 2001, Adult attention-deficit/hyperactivity disorder, Brain Cogn, 46, 114, 10.1016/S0278-2626(01)80046-4 Dougherty, 1999, Dopamine transporter density in patients with attention deficit hyperactivity disorder, Lancet, 354, 2132, 10.1016/S0140-6736(99)04030-1 Ebstein, 1997, Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of novelty seeking, Mol Psychiatry, 2, 472, 10.1038/sj.mp.4000333 Efron, 1997, Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder, Pediatrics, 100, 662, 10.1542/peds.100.4.662 Ernst, 1998, DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study, J Neurosci, 18, 5901, 10.1523/JNEUROSCI.18-15-05901.1998 Ernst, 1999, High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder, Am J Psychiatry, 156, 1209, 10.1176/ajp.156.8.1209 Faraone, 2003, The worldwide prevalence of ADHD, World J Biol Psychiatry, 2, 104 Files, 1989, Effects of methylphenidate on responding under extinction in the presence and absence of conditioned reinforcement, Behav Pharmacol, 1, 113, 10.1097/00008877-198900120-00002 Giedd, 2001, Brain imaging of attention deficit/hyperactivity disorder, Ann NY Acad Sci, 931, 33, 10.1111/j.1749-6632.2001.tb05772.x Gill, 1997, Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism, Mol Psychiatry, 2, 311, 10.1038/sj.mp.4000290 Golinko, 1984, Side effects of dextroamphetamine and methylphenidate in hyperactive children-a brief review, Prog Neuropsychopharmacol Biol Psychiatry, 8, 1, 10.1016/0278-5846(84)90129-5 Greenhill, 1999, Stimulant medications, J Am Acad Child Adolesc Psychiatry, 38, 503, 10.1097/00004583-199905000-00011 Greenhill, 2002, Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults, J Am Acad Child Adolesc Psychiatry, 41, 26S, 10.1097/00004583-200202001-00003 Heiligenstein, 1998, Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students, J Am Coll Health, 46, 185, 10.1080/07448489809595609 Hollerman, 1998, Dopamine neurons report an error in the temporal prediction of reward during learning, Nat Neurosci, 1, 304, 10.1038/1124 Ilgin, 2001, Is increased D2 receptor availability associated with response to stimulant medication in ADHD, Dev Med Child Neurol, 43, 755, 10.1017/S0012162201001384 Kiyatkin, 1996, Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats, J Neurophysiol, 75, 142, 10.1152/jn.1996.75.1.142 Konopacki, 1985, Amphetamine anorexia in cats, Acta Physiol Pol, 36, 267 Koob, 1996, Hedonic valence, dopamine and motivation, Mol Psychiatry, 1, 186 Krause, 2000, Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder, Neurosci Lett, 285, 107, 10.1016/S0304-3940(00)01040-5 Kuczenski, 1997, Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine, J Neurochem, 68, 2032, 10.1046/j.1471-4159.1997.68052032.x LaHoste, 1996, Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder, Mol Psychiatry, 1, 121 Marsteller, 2002, Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortex, Neuropsychopharmacology, 27, 163, 10.1016/S0893-133X(02)00288-9 Overmeyer, 2000, Neuroimaging in hyperkinetic children and adults, Pediatr Rehabil, 4, 57 Patrick, 1987, Pharmacology of the enantiomers of threo-methylphenidate, J Pharacol Exp Ther, 241, 152 Porrino, 1983, A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects, Arch Gen Psychiatry, 40, 688, 10.1001/archpsyc.1983.04390010098013 Pucak, 1994, Regulation of substantia nigra dopamine neurons, Crit Rev Neurobiol, 9, 67 Richardson, 1996, Behavior-relevant changes in nucleus accumbens dopamine transmission elicited by food reinforcement, J Neurosci, 16, 8160, 10.1523/JNEUROSCI.16-24-08160.1996 Rowe, 1998, Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder, Mol Psychiatry, 3, 419, 10.1038/sj.mp.4000432 Seeman, 1998, Anti-hyperactivity medication, Mol Psychiatry, 3, 386, 10.1038/sj.mp.4000421 Shenker, 1992, The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder, Adv Pediatr, 39, 337 Solanto, 1998, Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder, Behav Brain Res, 94, 127, 10.1016/S0166-4328(97)00175-7 Swanson, 1998, Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting, Psychopharmacol Bull, 34, 55 Swanson, 1991, Effects of stimulant medication on learning in children with ADHD, J Learn Disabil, 24, 219, 10.1177/002221949102400406 Swanson, 2002, Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD, J Am Acad Child Adolesc Psychiatry, 41, 1306, 10.1097/00004583-200211000-00011 Swanson, 1998, Attention-deficit hyperactivity disorder and hyperkinetic disorder, Lancet, 351, 429, 10.1016/S0140-6736(97)11450-7 Swanson, 1998, Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD), Mol Psychiatry, 3, 38, 10.1038/sj.mp.4000354 Teicher, 2000, Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry, Nat Med, 6, 470, 10.1038/74737 van Dyck, 2002, Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder, Am J Psychiatry, 159, 309, 10.1176/appi.ajp.159.2.309 Volkow, 1995, Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain, Arch Gen Psychiatry, 52, 456, 10.1001/archpsyc.1995.03950180042006 Volkow, 2001, Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain, J Neurosci, 21, RC121, 10.1523/JNEUROSCI.21-02-j0001.2001 Volkow, 1998, Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate, Am J Psychiatry, 155, 1325, 10.1176/ajp.155.10.1325 Volkow, 2002, “Nonhedonic” food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect, Synapse, 44, 175, 10.1002/syn.10075 Volkow, 1994, Imaging endogenous dopamine competition with [11C]raclopride in the human brain, Synapse, 16, 255, 10.1002/syn.890160402 Volkow, 2004, Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain, Am J Psychiatry, 161, 1173, 10.1176/appi.ajp.161.7.1173 Waldman, 1998, Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children, Am J Hum Genet, 63, 1767, 10.1086/302132 Wyvell, 2000, Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward, J Neurosci, 20, 8122, 10.1523/JNEUROSCI.20-21-08122.2000